Gastrointestinal Disease
Conditions
Keywords
propofol sedation endoscopy
Brief summary
Endoscopic sedation requires titration of propofol to deep sedation without minimum overshoot into general anesthesia. This skill is demanding and acquired slowly. Probability Ramp Control (PRC) simplifies this by providing the clinician with a simple infusion sequence that permits gradual titration of propofol. The purpose of this study is to compare the performance of this technology to that of experienced anesthesia providers in endoscopic sedation.
Detailed description
Administration of propofol to achieve a target of moderate sedation is a challenging task for which anesthesia providers receive minimal training. Undersedation results in a noncompliant patient, while oversedation results in airway obstruction, respiratory depression, and hypotension. Considerable variability in patient pharmacokinetics (the distribution of drug within the body) and pharmacodynamics (the translation of drug concentration to clinical effect) has been demonstrated. The skill of titrating propofol to the desired target and maintaining this state is slowly acquired in the clinical environment of the endoscopy center with frequent reliance on rescue skills. An automated system that facilitates this process would be useful. Pharmacokinetic models allow us to make predictions of the results of drug administration. If we know the age and size of the patient, we can determine a quantity of propofol that will attain a desired concentration at some point in the future (within the predictive accuracy of the model). If they are old, this is less than if they are young. If they are obese, this is more than if they are thin. By adjusting the dosing, we can achieve similar concentrations at a specified time in a wide range of patients. Pharmacodynamic models allow us to relate drug concentration to a probability of response. Sensitivity is a randomly distributed variable, and the cumulative probability of response to propofol is well represented by a sigmoid curve. While we do not know the concentration that will suffice for a given individual, we can determine the probability that this individual will lose responsiveness within an interval of concentrations. For example, the probability of loss of responsiveness between 1 µg/ml and 6 µg/ml is around 99%. For any given age and size, an infusion sequence can be determined so that we traverse this interval smoothly. The infusion sequence is determined by minimization of the difference between the simulated probability and the target (1). We predict that 90% of 50 year old 70 kg patients will lose responsiveness between one minute and three minutes after initiating the infusion, and 99% by five minutes. The infusion sequence for this patient is comprised of a bolus of 287 µg/kg followed by an initial infusion of 216 µg/kg/min, with an increase to 550 µg/kg/min after 147 seconds. By selecting the infusion sequence based on the age and size of the patient, all patients will track the same target line. These infusion rates are determined prior to initiation of sedation, and the clinician can verify that they are appropriate for the patient before beginning sedation. Once the endpoint of adequate sedation is observed, the effect site concentration associated with this endpoint is inferred, and the infusion that will maintain this concentration can be determined. This allows the clinical observation to be translated into an infusion rate, much as a driver accelerates to a desired speed and then engages the cruise control to maintain that speed. The intent of this study is to demonstrate equivalent safety and efficacy of PRC to control by a skilled clinician. References 1\. Mandel JE, Sarraf E. The Variability of Response to Propofol Is Reduced When a Clinical Observation Is Incorporated in the Control: A Simulation Study. Anesthesia & Analgesia. 2012;114:1221-9.
Interventions
Decision support software that calculates propofol doses appropriate for age and weight of the patient
Manual recording of drug doses determined by CRNA
Sponsors
Study design
Eligibility
Inclusion criteria
* scheduled for elective EGD
Exclusion criteria
* Unable to provide informed consent
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Number of Participants Requiring Adjustment in Propofol Dosing | Intraprocedure (average of 9 minutes) | Following initial sedation, an infusion rate for propofol is determined by the CRNA (control) or software (experimental). If this rate is appropriate for the duration of the brief procedure, no adjustment to the rate will be required. A greater requirement for rate changes suggests that the anesthesia provider needs to be immediately available to perform these adjustments. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Decrease in Minute Ventilation From Baseline | Duration of sedation (average of 25 minutes) | Minute ventilation as determined by respiratory inductance plethysmography from initiation of sedation until emergence. |
| Time Spent Below a Saturation of 80% | Duration of sedation (mean 25 minutes) | Number of seconds spent below saturation of 80%, reported as the total per group |
| Procedure Time | Procedure time (average of 9 minutes) | Time from endoscopic intubation until completion of the procedure. This is not really an outcome measure, but is used to assess balance between groups. |
Countries
United States
Participant flow
Participants by arm
| Arm | Count |
|---|---|
| Monitoring Standard of care sedation by CRNA using proposal with manual recording of drug dosing
Monitoring: Manual recording of drug doses determined by CRNA | 20 |
| Probability Ramp Control Propofol titrated to deep sedation using PRC software.
Probability ramp control: Decision support software that calculates propofol doses appropriate for age and weight of the patient | 20 |
| Total | 40 |
Baseline characteristics
| Characteristic | Total | Monitoring | Probability Ramp Control |
|---|---|---|---|
| Age, Continuous | 50.625 years STANDARD_DEVIATION 15.345 | 48.5 years STANDARD_DEVIATION 14.2 | 52.8 years STANDARD_DEVIATION 16.5 |
| ASA 3 | 15 Participants | 7 Participants | 8 Participants |
| Sex: Female, Male Female | 21 Participants | 8 Participants | 13 Participants |
| Sex: Female, Male Male | 19 Participants | 12 Participants | 7 Participants |
| Weight | 82.22 kg STANDARD_DEVIATION 25.4 | 82.3 kg STANDARD_DEVIATION 27.4 | 82.1 kg STANDARD_DEVIATION 23.9 |
Adverse events
| Event type | EG000 affected / at risk | EG001 affected / at risk |
|---|---|---|
| deaths Total, all-cause mortality | 0 / 20 | 0 / 20 |
| other Total, other adverse events | 1 / 20 | 0 / 20 |
| serious Total, serious adverse events | 0 / 20 | 0 / 20 |
Outcome results
Number of Participants Requiring Adjustment in Propofol Dosing
Following initial sedation, an infusion rate for propofol is determined by the CRNA (control) or software (experimental). If this rate is appropriate for the duration of the brief procedure, no adjustment to the rate will be required. A greater requirement for rate changes suggests that the anesthesia provider needs to be immediately available to perform these adjustments.
Time frame: Intraprocedure (average of 9 minutes)
| Arm | Measure | Value (COUNT_OF_PARTICIPANTS) |
|---|---|---|
| Monitoring | Number of Participants Requiring Adjustment in Propofol Dosing | 16 Participants |
| Probability Ramp Control | Number of Participants Requiring Adjustment in Propofol Dosing | 2 Participants |
Decrease in Minute Ventilation From Baseline
Minute ventilation as determined by respiratory inductance plethysmography from initiation of sedation until emergence.
Time frame: Duration of sedation (average of 25 minutes)
| Arm | Measure | Value (MEDIAN) |
|---|---|---|
| Monitoring | Decrease in Minute Ventilation From Baseline | 25 percentage of baseline |
| Probability Ramp Control | Decrease in Minute Ventilation From Baseline | 50 percentage of baseline |
Procedure Time
Time from endoscopic intubation until completion of the procedure. This is not really an outcome measure, but is used to assess balance between groups.
Time frame: Procedure time (average of 9 minutes)
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| Monitoring | Procedure Time | 9.03 minutes | Standard Deviation 3.75 |
| Probability Ramp Control | Procedure Time | 8.9 minutes | Standard Deviation 4.75 |
Time Spent Below a Saturation of 80%
Number of seconds spent below saturation of 80%, reported as the total per group
Time frame: Duration of sedation (mean 25 minutes)
| Arm | Measure | Value (COUNT_OF_UNITS) |
|---|---|---|
| Monitoring | Time Spent Below a Saturation of 80% | 168 seconds |
| Probability Ramp Control | Time Spent Below a Saturation of 80% | 22 seconds |